All In Biotech

Drug Trial Radar · NCT06574997

Expanded Access Program for RP in Adults

An Expanded Access Program for Retinitis Pigmentosa in Adults Aged 18 Years and Older

Last checked: Nov 19, 2026Latest source record: Oct 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

No longer available

Status

No longer available

Enrollment

Not stated

Start

Not stated

Primary completion

Not stated

Sponsor

Lead sponsor
OcugenIndustry
Sponsor type
Industry
First posted
Aug 28, 2024

More drug trials from this sponsor

Design

Study type
Expanded access
Who can join
All sexes, from 18 years, up to 99 years

Summary

As written by the sponsor on the registry.

This intermediate-size patient population expanded access program is to provide access to investigational product OCU400 for up to 75 patients with Retinitis Pigmentosa (RP) outside of the ongoing clinical trial Phase 3 program for patients who do not have access to alternative Food and Drug Administration (FDA)-approved products for treatment of the disease.

Conditions

  • Retinitis Pigmentosa

Interventions

  • OCU400Drug

    Participants will receive a subretinal injection of OCU400 modifier gene therapy product.

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Associated Retina Consultants

    Phoenix, Arizona

  • Advanced Research

    Deerfield Beach, Florida

  • Erie Retina Research

    Erie, Pennsylvania

  • Valley Retina Institute

    McAllen, Texas

  • Gundersen Health

    La Crosse, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.